Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Sell
2,381
-840
-26% -$71.7K ﹤0.01% 1390
2026
Q1
$289K Buy
+3,221
New +$309K ﹤0.01% 1083
2025
Q2
Sell
-10,931
Closed -$1.15M 1815
2025
Q1
$1.15M Buy
+10,931
New +$1.14M 0.03% 413
2024
Q4
Sell
-12,542
Closed -$1.34M 2028
2024
Q3
$1.34M Buy
12,542
+6,686
+114% +$676K 0.03% 675
2024
Q2
$580K Buy
5,856
+523
+10% +$52.6K 0.01% 1061
2024
Q1
$493K Sell
5,333
-1,260
-19% -$101K 0.01% 1001
2023
Q4
$498K Buy
+6,593
New +$429K 0.01% 962
2023
Q3
Sell
-9,368
Closed -$675K 1885
2023
Q2
$675K Buy
9,368
+1,793
+24% +$113K 0.01% 698
2023
Q1
$420K Buy
+7,575
New +$418K 0.01% 911
2021
Q2
Sell
-3,647
Closed -$323K 1497
2021
Q1
$323K Buy
+3,647
New +$361K 0.01% 729

Other funds holding ITRI

Centiva Capital's ITRI Position: Q2 2026 in Review

Centiva Capital reduced its Itron (ITRI) stake by 26% in Q2 2026, selling an estimated $71.7K and leaving 2,381 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

Centiva Capital first reported a position in ITRI in Q1 2021 and has held it in 10 quarters since. The position peaked at $1.34M in Q3 2024. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Centiva Capital held 2,381 shares of Itron worth $206K as of Q2 2026.
  • Centiva Capital sold 840 Itron shares in Q2 2026, an estimated $71.7K.
  • Itron made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1390 holding.
  • Centiva Capital first reported a position in Itron in Q1 2021 and has held it in 10 quarters since.
  • Centiva Capital's Itron position peaked at $1.34M in Q3 2024.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.